4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-25-090429
Chief Medical Officer sold 7,848 shares at $6.80 ($53,366)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Daniel Chief Medical Officer | 2025-06-25 | Sale 10b5-1 | −7,848 | $6.80 | $53,366 | 438,329 | D: show line 1 in the form |
| Open-market sales · 7,848 sh · avg $6.80 · $53,366 | |||||||
Loading xslF345X05/ownership.xml…